Benitec Biopharma (BNTC) Assets Average (2020 - 2025)
Benitec Biopharma (BNTC) posted Assets Average of $143.4 million for Q4 2025, up 46.56% sequentially from $97.8 million in Q3 2025, and up 93.93% YoY from $73.9 million in Q4 2024.
Benitec Biopharma (BNTC) Assets Average (2020 - 2025) Analysis & Trends
Benitec Biopharma has reported Assets Average for 6 years, with the latest figure at $143.4 million in Q4 2025.
- Quarterly Assets Average rose 93.93% year-over-year to $143.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $143.4 million (up 93.93% YoY) and the FY2025 annual result came in at $75.9 million, up 167.85% from the prior year.
- Assets Average improved to $143.4 million in Q4 2025 per BNTC's latest filing, from $97.8 million in the prior quarter.
- Over five years, Assets Average peaked at $143.4 million in Q4 2025 and troughed at $6.3 million in Q2 2023.
- A 5-year average of $33.2 million and a median of $16.7 million in 2021 frame the typical range for Assets Average.
- The sharpest annual moves came in 2022 and 2024: Assets Average sank 53.93% in 2022, then surged 429.87% in 2024.
- Over 5 years, Assets Average stood at $15.9 million in 2021, then dropped by 5.75% to $15.0 million in 2022, then soared by 61.25% to $24.2 million in 2023, then surged by 205.42% to $73.9 million in 2024, then surged by 93.93% to $143.4 million in 2025.
- According to Business Quant data, Assets Average over the past three periods registered $143.4 million, $97.8 million, and $73.9 million for Q4 2025, Q3 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Benitec Biopharma | 577.39 Mn | 388.49 Mn | - | 143.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 143.35 Mn |
| Sep 30, 2025 | 97.81 Mn |
| Dec 31, 2024 | 73.92 Mn |
| Sep 30, 2024 | 60.49 Mn |
| Jun 30, 2024 | 33.60 Mn |
| Mar 31, 2024 | 18.18 Mn |
| Dec 31, 2023 | 24.20 Mn |
| Sep 30, 2023 | 15.76 Mn |
| Jun 30, 2023 | 6.34 Mn |
| Mar 31, 2023 | 10.06 Mn |
| Dec 31, 2022 | 15.01 Mn |
| Sep 30, 2022 | 12.04 Mn |
| Jun 30, 2022 | 8.02 Mn |
| Mar 31, 2022 | 12.04 Mn |
| Dec 31, 2021 | 15.93 Mn |
| Sep 30, 2021 | 19.61 Mn |
| Jun 30, 2021 | 17.40 Mn |
| Mar 31, 2021 | 14.47 Mn |
| Dec 31, 2020 | 12.21 Mn |
| Sep 30, 2020 | 10.25 Mn |